Pamela M. Sutton-Wallace
President, Yale New Haven Health System (YNHHS)
Affiliations
- •President, Yale New Haven Health System (Feb 2024–present): Reports to CEO Christopher O'Connor. Drives enterprise strategy across clinical services and community health. Previously served as EVP & Chief Operating Officer (July 2022–Feb 2024), where she improved revenue cycle operations and halved the system's operating deficit. Established YNHHS Automation Center of Excellence.
- •NewYork-Presbyterian Hospital / Weill Cornell (2019–2022): Group Senior Vice President & COO, Weill Cornell Division. Oversaw four campuses (Weill Cornell, Lower Manhattan, Brooklyn, Queens) totaling 1,500+ inpatient beds plus ambulatory network.
- •University of Virginia Health System (2014–2019/2020): CEO, UVA Medical Center. Oversaw $2.2B budget. Led UVA to #1 hospital ranking in Virginia (US News & World Report) and first Leapfrog "A" safety grade. Also served as interim leader of UVA Health Enterprise (School of Medicine, Medical Center, Health System Library).
- •Duke University Health System (1997–2014): 17 years of progressive leadership. Roles included SVP Hospital Operations at Duke University Hospital, COO for Ambulatory Services, VP for Perioperative Services, and Chief of Staff to the Chancellor for Health Affairs. Began as Health Services Management Fellow.
- •Early Career: Positions at Pfizer (pharmaceutical) and Blue Cross Blue Shield of North Carolina (insurance).
- •MPH, Yale University School of Public Health (1997)
- •BA, Political Science & African American Studies, Washington University in St. Louis
- •Consensus Cloud Solutions, Inc. — Independent Director (publicly traded; CCSI on Nasdaq). Received $217,525 total compensation in 2021 ($17,500 cash, $200,025 equity).
Financial / Compensation
- •Consensus Cloud Solutions (CCSI) Board: $217,525 total compensation (2021) — $17,500 cash, $200,025 equity grants. Public company board seat provides independent income stream and corporate governance exposure outside the nonprofit hospital sector.
- •UVA Medical Center (state employee, public record): Multiple salary records exist on OpenPayrolls.com for her tenure as CEO of UVA Medical Center (2014–2019). As a Virginia state employee, her compensation was publicly reported. UVA Medical Center CEO compensation was in the range typical for academic medical center CEOs ($800K–$1.2M total).
- •Yale New Haven Health (nonprofit, Form 990): Specific compensation not yet available in public 990 filings covering her tenure as President (promoted Feb 2024). Her COO-period compensation should appear on YNHHS Form 990 Schedule J filings for FY2023 or FY2024. For reference, YNHHS CEO Christopher O'Connor and predecessor Marna Borgstrom have historically received total compensation packages exceeding $3–5 million annually. As President reporting to the CEO, Sutton-Wallace's package likely falls in the $2–4M range. Action item: Monitor ProPublica Nonprofit Explorer (EIN 06-0646652 for Yale New Haven Hospital; EIN 22-2529464 for YNHHS Corp) for updated 990 filings.
- •Operating Revenue (FY2022): ~$5.4 billion (32.2% of all CT hospital system revenue)
- •FY2024 Surplus: $46.2 million — first surplus since 2019, a dramatic turnaround from losses of $162.3M (FY2023) and $240.3M (FY2022). Sutton-Wallace credited with operational improvements that halved the deficit.
- •Total Liabilities (FY2024): $4.33 billion (up from $4.05B prior year)
- •Long-Term Debt: ~$1.7 billion (FY2024), up from $670M in 2019 — a 153% increase in five years, reflecting debt-financed expansion.
- •Health System Fees: System fees at CT hospitals more than doubled statewide from ~$748M (FY2017) to $1.6B+ (FY2024). YNHHS is a primary driver as the state's largest system. These fees — charged on top of professional fees when care is delivered at hospital-owned outpatient sites — are a direct consequence of physician practice acquisitions and facility reclassification.
Lobbying and Political
- •YNHHS is a dominant player in Connecticut's CON process. The system's administrative, legal, and lobbying capacity gives it an outsized advantage in navigating CON requirements. As Sen. Ryan Fazio (R-Greenwich) noted: "The Yale New Havens of the world are going to have the administrative, the legal, the lobbying capacity to manage that," while smaller organizations cannot.
- •Proton therapy center case study: A proposed Danbury Proton therapy center was denied through the CON process at OHS, while lobbying by YNHHS and Hartford HealthCare led to approval for a joint proton therapy facility in Wallingford — effectively blocking a competitor while securing the same service for themselves.
- •Prospect acquisition CON (16-month process): The CON application for YNHHS's acquisition of three Prospect Medical Holdings hospitals (Waterbury, Manchester Memorial, Rockville General) took 16 months to approve, drawing criticism from patients, local leaders, and workers. The Office of Health Strategy ultimately approved the deal with conditions in March 2024.
- •Connecticut's CON program has been characterized as favoring large incumbent systems. An opinion piece in the Darien Times stated: "Big hospital systems know how to lobby in Connecticut. While other states scaled back on protectionist laws that stifle health care competition in 2023, industry insiders in Hartford pushed through legislation that does the opposite."
- •Lofty plans for major CON program reform dissolved in the final weeks of the 2024 CT legislative session as health officials failed to reach consensus with state leaders — a result that benefits incumbents like YNHHS who thrive under the current framework.
- •Sen. Fazio cited research that CON programs nationally "have mostly failed to limit spending or improve quality and access" and argued the regulatory burden actually increases consolidation — benefiting systems like YNHHS.
- •Lawrence + Memorial Hospital acquisition: In L+M's primary service area, YNHHS grew from 14% to 83% market share post-acquisition, leaving few alternatives in an already concentrated market.
- •Prospect Medical Holdings acquisition (2024): Added Waterbury Hospital (357 beds), Manchester Memorial (249 beds), and Rockville General (102 beds). If completed, YNHHS would control ~35.37% of all CT hospital operating revenue.
Red Flags
In March 2025, YNHHS identified a cyberattack affecting 5.6 million patient records — one of the largest healthcare data breaches in U.S. history.
YNHHS agreed to an $18M class action settlement. After attorneys' fees and costs, the per-person payout amounts to roughly $2 per affected individual — widely criticized as inadequate.
Allegations included negligence, breach of fiduciary duty, breach of implied contract, unjust enrichment, and failure to adequately protect sensitive patient data.
YNHHS and affiliate Northeast Medical Group settled federal and state False Claims Act allegations for billing fraud between July 2014 and June 2020.
The system submitted claims billed at physician rates for work performed by nurses and physician assistants, receiving Medicare/Medicaid reimbursements 10–15% higher than warranted.
The case originated from a whistleblower filing under the False Claims Act's qui tam provisions.
A class action lawsuit alleged YNHH charged uninsured patients inflated rates and employed "aggressive, abusive, and humiliating" collection practices including lawsuits, liens, and wage garnishments.
The 2003 Connecticut Center for a New Economy report *Uncharitable Care* documented these practices in detail, creating a lasting reputational stain.
The core allegation: YNHH promised to "operate on a non-profit basis and provide health care services to all Connecticut residents regardless of ability to pay" while doing the opposite for uninsured patients.
Health system fees at CT hospitals doubled from ~$748M (FY2017) to $1.6B+ (FY2024). YNHHS, as the state's largest system, is a primary contributor.
Research cited by Connecticut Public suggests consolidation drives up healthcare spending without producing significant patient benefits.
YNHHS defends the fees as supporting "economy of scale" services including EHR and IT infrastructure, but critics view them as a consolidation tax on patients and payers.
YNHHS's tax-exempt status since 1966 provides substantial federal, state, and local tax benefits. The gap between the value of tax exemptions received and charity care/community benefit provided has been a persistent point of criticism.
The $6M/3-year community benefit commitment attached to the Prospect acquisition represents roughly 0.04% of annual system revenue — raising questions about proportionality.
YNHHS controls ~32–35% of CT hospital operating revenue and achieved 83% market share in the L+M service area post-acquisition.
This concentration creates pricing power concerns: fewer alternatives for patients and payers, reduced competition, and upward pressure on costs.
The system's growth trajectory (from 5 hospitals to 8) positions it to control an even larger share of Connecticut's healthcare market.
Long-term debt grew from $670M (2019) to $1.7B (2024) — a 153% increase in five years.
Total liabilities reached $4.33B in FY2024. While the system returned to surplus ($46.2M), the debt load relative to margins raises sustainability questions if volumes or reimbursement soften.
Pattern Summary
Sutton-Wallace's career arc follows the classic academic medical center executive pipeline: administrative fellowship at Duke → 17 years of progressive operational leadership at Duke → CEO of a flagship academic medical center (UVA) → COO of a marquee NYC system (NYP/Weill Cornell) → President of Connecticut's dominant health system (YNHHS). Each move expanded scope, budget, and institutional prestige.